Klingenstein Fields & Co. LP Has $2.84 Million Stock Holdings in The Allstate Co. (NYSE:ALL)

Klingenstein Fields & Co. LP lessened its position in The Allstate Co. (NYSE:ALL) by 25.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 14,973 shares of the insurance provider’s stock after selling 5,210 shares during the period. Klingenstein Fields & Co. LP’s holdings in Allstate were worth $2,840,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. BDF Gestion acquired a new position in Allstate during the 2nd quarter worth about $3,051,000. BNP Paribas Financial Markets lifted its position in Allstate by 55.8% during the 1st quarter. BNP Paribas Financial Markets now owns 218,629 shares of the insurance provider’s stock valued at $37,825,000 after purchasing an additional 78,316 shares during the period. OFI Invest Asset Management bought a new stake in shares of Allstate in the 2nd quarter valued at about $476,000. Envestnet Portfolio Solutions Inc. increased its stake in shares of Allstate by 12.5% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 50,383 shares of the insurance provider’s stock valued at $8,717,000 after acquiring an additional 5,586 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in shares of Allstate by 251.8% in the 1st quarter. SG Americas Securities LLC now owns 53,090 shares of the insurance provider’s stock valued at $9,185,000 after acquiring an additional 38,001 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Trading Down 1.3 %

NYSE ALL opened at $184.15 on Monday. The company has a market cap of $48.76 billion, a PE ratio of 11.93, a PEG ratio of 1.88 and a beta of 0.48. The company has a current ratio of 0.40, a quick ratio of 0.36 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 12 month low of $127.93 and a 12 month high of $198.79. The stock has a 50 day moving average of $188.87 and a 200-day moving average of $175.32.

Allstate (NYSE:ALL) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same quarter in the prior year, the firm posted $0.81 EPS. The firm’s revenue for the quarter was up 14.7% compared to the same quarter last year. On average, equities research analysts anticipate that The Allstate Co. will post 14.16 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on ALL shares. Jefferies Financial Group upped their price target on Allstate from $217.00 to $231.00 and gave the company a “buy” rating in a research note on Wednesday, October 9th. Keefe, Bruyette & Woods increased their target price on Allstate from $199.00 to $208.00 and gave the stock an “outperform” rating in a research note on Monday, August 12th. Piper Sandler increased their target price on Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a research note on Friday, August 16th. The Goldman Sachs Group increased their target price on Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research note on Thursday, August 15th. Finally, Roth Mkm reaffirmed a “buy” rating and set a $200.00 price target on shares of Allstate in a research report on Wednesday, August 14th. One research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $207.19.

Insider Buying and Selling at Allstate

In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares of the company’s stock, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Allstate news, EVP Robert Toohey sold 16,682 shares of the firm’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the completion of the sale, the executive vice president now owns 4,873 shares of the company’s stock, valued at $877,968.41. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the sale, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at $3,431,901.67. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 192,530 shares of company stock valued at $34,967,665 in the last quarter. 1.80% of the stock is currently owned by insiders.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.